| 24 May 2026 |
CJC-1295 With DAC |
6.4 |
5mg |
4.5mg |
-9.2% |
97.67% |
Lab E |
| 24 May 2026 |
DHB (1-Test Cyp) Oral |
8.3 |
100mg |
120.9mg |
+20.9% |
96.81% |
Lab F |
| 24 May 2026 |
NAD+ |
8.2 |
15mg |
16.1mg |
+7.6% |
96.66% |
Lab G |
| 24 May 2026 |
BAM15 |
5.2 |
20mg |
18.6mg |
-7.2% |
95.07% |
Lab E |
| 24 May 2026 |
Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) |
6.2 |
300mg/ml |
259.8mg/ml |
-13.4% |
95.77% |
Lab E |
| 24 May 2026 |
SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) |
8.4 |
100mg/ml |
101.0mg/ml |
+1.0% |
98.56% |
Lab E |
| 24 May 2026 |
HGH Fragment 176-191 |
8.7 |
10mg |
11.2mg |
+12.1% |
96.93% |
Lab E |
| 24 May 2026 |
Tirzepatide Oral |
6.5 |
100mg |
96.5mg |
-3.5% |
97.27% |
Lab G |
| 23 May 2026 |
Arimidex (Anastrozole) |
7.9 |
100mg |
93.3mg |
-6.7% |
99.74% |
Lab E |
| 23 May 2026 |
Semax |
5.1 |
2mg |
1.9mg |
-4.7% |
96.88% |
Lab F |
| 21 May 2026 |
AICAR |
7.2 |
20mg |
19.6mg |
-2.0% |
99.24% |
Lab D |
| 21 May 2026 |
Masteron P (Drostanolone P) |
4.7 |
300mg/ml |
274.7mg/ml |
-8.4% |
97.07% |
Lab G |
| 21 May 2026 |
PEG MGF |
4.0 |
30mg |
28.1mg |
-6.4% |
96.90% |
Lab B |
| 17 May 2026 |
BPC157 5mg + TB500 5mg Blend |
5.9 |
2mg |
2.1mg |
+4.4% |
96.68% |
Lab G |
| 29 Jan 2026 |
Livagen |
4.0 |
20mg |
21.6mg |
+8.2% |
96.41% |
Lab G |
| 26 Jan 2026 |
NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 |
9.1 |
5g |
4.9g |
-1.6% |
96.57% |
Lab E |
| 9 Jan 2026 |
VIP |
4.0 |
15mg |
13.4mg |
-10.4% |
97.04% |
Lab C |
| 7 Jan 2026 |
HCG |
5.4 |
20mg |
21.1mg |
+5.6% |
95.77% |
Lab C |
| 29 Dec 2025 |
Clenbuterol |
4.7 |
100mg |
88.2mg |
-11.8% |
95.96% |
Lab C |
| 29 Dec 2025 |
Proviron (Mesterolone) |
5.6 |
25mg |
30.5mg |
+21.9% |
97.98% |
Lab E |
| 12 Dec 2025 |
AA Water |
9.5 |
20mg |
24.6mg |
+23.1% |
96.22% |
Lab F |
| 5 Dec 2025 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
5.1 |
5mg |
5.3mg |
+7.0% |
97.84% |
Lab F |
| 17 Nov 2025 |
AHK-CU |
5.3 |
20mg |
23.2mg |
+15.8% |
97.38% |
Lab F |
| 17 Nov 2025 |
Cardiogen |
5.3 |
30mg |
35.2mg |
+17.2% |
99.91% |
Lab E |
| 17 Nov 2025 |
Letrozole |
5.1 |
100mg |
124.4mg |
+24.4% |
96.06% |
Lab A |
| 17 Nov 2025 |
Primobolan Oral (Methenolone Acetate) |
9.9 |
10mg |
10.2mg |
+2.0% |
98.28% |
Lab E |
| 14 Nov 2025 |
Epithalon |
6.7 |
5mg |
5.2mg |
+3.7% |
98.68% |
Lab F |
| 5 Nov 2025 |
Turinabol |
7.3 |
25mg |
26.9mg |
+7.8% |
96.20% |
Lab E |
| 4 Nov 2025 |
Liraglutide |
4.0 |
20mg |
23.4mg |
+17.1% |
97.44% |
Lab F |
| 4 Nov 2025 |
Methylene Blue |
5.9 |
25mg |
30.9mg |
+23.6% |
99.76% |
Lab F |
| 4 Nov 2025 |
T3 (Liothyronine) |
7.1 |
25mg |
25.9mg |
+3.7% |
96.31% |
Lab E |
| 17 Oct 2025 |
1-Boc-4-piperidone (tert-butyl 4-oxopiperidine-1-carboxylate) CAS 79099-07-3 |
8.6 |
5g |
4.8g |
-3.1% |
97.33% |
Lab C |
| 9 Oct 2025 |
Alprostadil |
4.0 |
20mg |
19.1mg |
-4.4% |
98.05% |
Lab D |
| 9 Oct 2025 |
Blend 500 (Tren E/Mast E) |
5.8 |
300mg/ml |
279.9mg/ml |
-6.7% |
96.83% |
Lab E |
| 9 Oct 2025 |
Halotestin (Fluoxymesterone) |
5.6 |
20mg |
18.7mg |
-6.5% |
97.29% |
Lab G |
| 9 Oct 2025 |
PTD-DBM |
8.2 |
5mg |
4.7mg |
-6.5% |
95.95% |
Lab C |
| 5 Oct 2025 |
Retatrutide |
7.9 |
10mg |
9.62mg |
-3.8% |
99.85% |
Lab E |
| 4 Sep 2025 |
Retatrutide |
7.9 |
10mg |
10mg |
|
99.85% |
Lab E |
| 9 Jul 2025 |
Retatrutide |
0.0 |
10mg |
⚠️ Sample does not contain Retatrutide ? |
(no batch ID) |
No Label / Silver Crimp / White Cap |
|
| 20 Jun 2025 |
Retatrutide |
7.6 |
10mg |
9.85mg |
-1.5% |
99.75% |
Lab E |